Phase II study of ionidamine in patients with metastatic breast cancer - An Eastern Cooperative Oncology Group study

H. Ian Robins; Donna S. Neuberg; Al B. Benson; Kishan J. Pandya; Douglass C. Tormey

doi:10.1007/BF00198600

Phase II study of ionidamine in patients with metastatic breast cancer - An Eastern Cooperative Oncology Group study

H. Ian Robins^*, Donna S. Neuberg, Al B. Benson, Kishan J. Pandya, Douglass C. Tormey

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The Eastern Cooperative Oncology Group conducted a phase II study of lonidamine in patients with metastatic breast cancer. The drug was given orally to a maximum daily dose of 340 mg/m². Forty-two patients were entered on study. One partial response was observed; there were no life-threatening toxicities. The results of this study are compared to two similar phase II trials.

Original language	English (US)
Pages (from-to)	397-399
Number of pages	3
Journal	Investigational New Drugs
Volume	8
Issue number	4
DOIs	https://doi.org/10.1007/BF00198600
State	Published - Nov 1990

Funding

Keywords

breast cancer
lonidamine

ASJC Scopus subject areas

Pharmacology (medical)
Oncology
Pharmacology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/BF00198600

Cite this

@article{7e7c084860cd47a09e7321eb83d6b536,

title = "Phase II study of ionidamine in patients with metastatic breast cancer - An Eastern Cooperative Oncology Group study",

abstract = "The Eastern Cooperative Oncology Group conducted a phase II study of lonidamine in patients with metastatic breast cancer. The drug was given orally to a maximum daily dose of 340 mg/m2. Forty-two patients were entered on study. One partial response was observed; there were no life-threatening toxicities. The results of this study are compared to two similar phase II trials.",

keywords = "breast cancer, lonidamine",

author = "Robins, {H. Ian} and Neuberg, {Donna S.} and Benson, {Al B.} and Pandya, {Kishan J.} and Tormey, {Douglass C.}",

year = "1990",

month = nov,

doi = "10.1007/BF00198600",

language = "English (US)",

volume = "8",

pages = "397--399",

journal = "Investigational New Drugs",

issn = "0167-6997",

publisher = "Kluwer Academic Publishers",

number = "4",

}

TY - JOUR

T1 - Phase II study of ionidamine in patients with metastatic breast cancer - An Eastern Cooperative Oncology Group study

AU - Robins, H. Ian

AU - Neuberg, Donna S.

AU - Benson, Al B.

AU - Pandya, Kishan J.

AU - Tormey, Douglass C.

PY - 1990/11

Y1 - 1990/11

N2 - The Eastern Cooperative Oncology Group conducted a phase II study of lonidamine in patients with metastatic breast cancer. The drug was given orally to a maximum daily dose of 340 mg/m2. Forty-two patients were entered on study. One partial response was observed; there were no life-threatening toxicities. The results of this study are compared to two similar phase II trials.

AB - The Eastern Cooperative Oncology Group conducted a phase II study of lonidamine in patients with metastatic breast cancer. The drug was given orally to a maximum daily dose of 340 mg/m2. Forty-two patients were entered on study. One partial response was observed; there were no life-threatening toxicities. The results of this study are compared to two similar phase II trials.

KW - breast cancer

KW - lonidamine

UR - http://www.scopus.com/inward/record.url?scp=0025104186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025104186&partnerID=8YFLogxK

U2 - 10.1007/BF00198600

DO - 10.1007/BF00198600

M3 - Article

C2 - 2084074

AN - SCOPUS:0025104186

SN - 0167-6997

VL - 8

SP - 397

EP - 399

JO - Investigational New Drugs

JF - Investigational New Drugs

IS - 4

ER -

Phase II study of ionidamine in patients with metastatic breast cancer - An Eastern Cooperative Oncology Group study

Abstract

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this